5 Dividend Stocks to Buy and Hold

2. AbbVie Inc (NYSE:ABBV)

Number of Hedge Fund Holders: 81

Dividend Yield: 4.8%

AbbVie Inc (NYSE:ABBV) is a publicly-traded biopharmaceuticals corporation. The company was founded not long ago, in 2013, and originated as an Abbott Laboratories spinoff. Regardless, because of its continued dividend hikes for 50 years in a row, it is now among the top dividend stocks to buy and hold.

Robyn Karnauskas from Truist also raised the price target on shares of AbbVie Inc (NYSE:ABBV), while reiterated a Buy rating on the stock as of this November.

The earnings history for AbbVie Inc (NYSE:ABBV) shows that in the third quarter, the company had an EPS of $3.33, beating estimates by $0.11. The revenue reported was $14.34 billion, up 11.33% year over year and beating estimates by $43.28 million. AbbVie Inc (NYSE:ABBV) has also gained 3.58% in the past six months and 12.57% year to date.

Our hedge fund data collected by tracking 867 hedge funds shows that 81 hedge funds held stakes in AbbVie Inc (NYSE:ABBV) in the third quarter of 2021, worth $4.1 billion. The number of hedge funds holding stakes in the company in the second quarter was 82, worth about $5.4 billion.